N. Vardakis

发表

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

S. Agelaki, V. Georgoulias, M. Perraki, 2013, British Journal of Cancer.

Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.

S. Agelaki, V. Georgoulias, K. Syrigos, 2011, Clinical lung cancer.

Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.

S. Agelaki, V. Georgoulias, D. Mavroudis, 2007, Digestive diseases.

A Dose Escalation Study of the Biweekly Administration of Paclitaxel, Oxaliplatin and Capecitabine in Patients with Advanced Solid Tumors

D. Mavroudis, V. Georgoulias, A. Kalykaki, 2007, Oncology.

WITHDRAWN: Irinotecan plus Weekly 5-Fluorouracil and Leucovorin as Salvage Treatment for Patients with Metastatic Colorectal Cancer: A Phase II Trial

S. Agelaki, V. Georgoulias, D. Mavroudis, 2007, Digestive Diseases.

A Dose Escalating Study of Oxaliplatin and High Dose Weekly Leucovorin and 5-Fluorouracil in Patients with Advanced Solid Tumors

S. Agelaki, V. Georgoulias, D. Mavroudis, 2005, Cancer investigation.

Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.

S. Agelaki, V. Georgoulias, N. Athanasiadis, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study

V. Georgoulias, N. Malamos, G. Samonis, 2001, Oncology.

A Dose-Finding Study of Irinotecan (CPT-11) plus a Four-Day Continuous 5-Fluorouracil Infusion in Advanced Colorectal Cancer

V. Georgoulias, D. Mavroudis, J. Souglakos, 2001, Oncology.

A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer

V. Georgoulias, K. Syrigos, S. Agelaki, 2004, Oncology.

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.

S. Agelaki, V. Georgoulias, N. Vardakis, 2001, Lung cancer.

A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancer.

V. Georgoulias, A. Voutsina, S. Agelaki, 2012, Clinical lung cancer.

Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

M. Kontogianni, S. Agelaki, D. Mavroudis, 2021, Translational lung cancer research.

Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study.

V. Georgoulias, A. Kalykaki, A. Polyzos, 2010, Lung cancer.

Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study

V. Georgoulias, A. Soultati, A. Kalykaki, 2012, Cancer Chemotherapy and Pharmacology.

A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC

V. Georgoulias, I. Varthalitis, A. Pallis, 2011, Cancer Chemotherapy and Pharmacology.

Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy

N. Ziras, J. Souglakos, A. Polyzos, 2008, Oncology.

Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer.

S. Agelaki, V. Georgoulias, J. Souglakos, 2001, Lung cancer.

A retrospective analysis of non-platinum-based first- and second-line chemotherapy in patients with advanced non-small cell lung cancer.

S. Agelaki, V. Georgoulias, A. Kalykaki, 2010, Anticancer research.

A Dose Escalation Study of Gemcitabine plus Pemetrexed Administered Biweekly in Patients with Solid Tumors

S. Agelaki, D. Mavroudis, V. Georgoulias, 2007, Oncology.

A Phase I Clinical Trial of Topotecan Given Every 2 Weeks in Patients with Refractory Solid Tumors

S. Agelaki, V. Georgoulias, D. Mavroudis, 2001, Oncology.

A Dose Escalation Study of Biweekly Oral Vinorelbine and Gemcitabine in Patients with Solid Tumors

S. Agelaki, M. Ignatiadis, V. Georgoulias, 2007, Oncology.

151P Personalized approach to mammography screening during the COVID pandemic: How to make up for lost time without losing effectiveness

S. Agelaki, K. Michailidou, A. Hadjisavvas, 2022, Annals of Oncology.

A dose escalation study of weekly docetaxel in patients with advanced solid tumors

S. Agelaki, V. Georgoulias, G. Samonis, 2000, Cancer Chemotherapy and Pharmacology.

Oxaliplatin (L-OHP) combined with irinotecan (CPT-11), leucovorin (LV) and fluorouracil (5-FU) compared with irinotecan, leucovorin and fluorouracil as first-line treatment for metastatic colorectal cancer (MCC): Preliminary results of a multicenter randomized phase III trial.

N. Ziras, J. Souglakos, A. Polyzos, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.

V. Georgoulias, D. Mavroudis, J. Souglakos, 2003, International journal of radiation oncology, biology, physics.

A 52-year-old-male patient with metastatic non-small-cell lung cancer and recurrent venous thromboembolism in unusual sites despite anticoagulation

V. Georgoulias, J. Souglakos, A. Matikas, 2013, BMJ Case Reports.

A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors

D. Mavroudis, V. Georgoulias, M. Marselos, 2008, Cancer Chemotherapy and Pharmacology.

Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.

M. Dimopoulos, V. Georgoulias, C. Papadimitriou, 1997, Seminars in oncology.

Acute onset of dermatomyositis presenting in pregnancy with rhabdomyolysis and fetal loss.

P. Malliotakis, D. Kofteridis, N. Vardakis, 1999, Scandinavian journal of rheumatology.

Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study.

V. Georgoulias, J. Syrios, A. Polyzos, 2019, Minerva ginecologica.

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.

I. Vlachonikolis, D. Mavroudis, V. Georgoulias, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.

S. Agelaki, V. Georgoulias, G. Samonis, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer

V. Georgoulias, G. Samonis, N. Ziras, 2011, Cancer Chemotherapy and Pharmacology.

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.

M. Dimopoulos, V. Georgoulias, C. Papadimitriou, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Front-Line T reatment o f A dvanced N on-Small-Cell Lung C ancer W ith D ocetaxel a nd G emcitabine: A M ulticenter P hase I I T rial

M. Dimopoulos, V. Georgoulias, C. Papadimitriou, 1999 .

Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group

V. Georgoulias, I. Boukovinas, N. Ziras, 2022, Current oncology.

Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group

V. Georgoulias, I. Boukovinas, P. Economopoulou, 2018, Annals of gastroenterology.

Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.

V. Georgoulias, G. Samonis, D. Mavroudis, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).

D. Mavroudis, V. Georgoulias, I. Boukovinas, 2008, Anticancer research.

Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study.

V. Georgoulias, D. Mavroudis, P. Cordopatis, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract

V. Georgoulias, N. Ziras, N. Karachaliou, 2010, Oncology.

Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study.

V. Georgoulias, I. Dimopoulou, C. Papadimitriou, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

A Dose-Escalation Study of Pegylated Liposomal Doxorubicin and Oxaliplatin in Patients with Advanced Solid Tumors

S. Agelaki, V. Georgoulias, A. Kalykaki, 2007, Oncology.

Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimen.

M. Dimopoulos, V. Georgoulias, T. Kotsakis, 1997, Seminars in oncology.

Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study.

S. Agelaki, D. Mavroudis, V. Georgoulias, 2003, Lung cancer.

Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer

V. Georgoulias, J. Souglakos, M. Sfakianaki, 2018, Cancer Chemotherapy and Pharmacology.

Imaging , Diagnosis , Prognosis Prognostic Significance of the Detection of Peripheral Blood CEACAM 5 mRNA-Positive Cells by Real-Time Polymerase Chain Reaction in Operable Colorectal Cancer

D. Mavroudis, V. Georgoulias, M. Perraki, 2010 .

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group

V. Georgoulias, S. Agelaki, I. Varthalitis, 2013, Journal of chemotherapy.

Sequential administration of docetaxel followed by maintenance gefitinib, as salvage treatment in patients with advanced NSCLC: a multicenter phase II trial.

S. Agelaki, V. Georgoulias, A. Kalykaki, 2007, Lung cancer.

Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)

V. Georgoulias, P. Economopoulou, A. Polyzos, 2017, Clinical and Translational Oncology.

A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer

V. Georgoulias, N. Karachaliou, D. Mavroudis, 2012, Cancer Chemotherapy and Pharmacology.

Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab

D. Mavroudis, V. Georgoulias, A. Kalykaki, 2011, Cancer Chemotherapy and Pharmacology.

Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.

S. Agelaki, V. Georgoulias, A. Kalykaki, 2011, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer

S. Agelaki, V. Georgoulias, I. Boukovinas, 2014, Cancer Chemotherapy and Pharmacology.

Docetaxel vs. vinorelbine in elderly patients with advanced non--small-cell lung cancer: a hellenic oncology research group randomized phase III study.

V. Georgoulias, A. Pallis, N. Vardakis, 2011, Clinical lung cancer.

Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group

V. Georgoulias, I. Boukovinas, J. Souglakos, 2017, Annals of gastroenterology.

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumor cells in patients with early breast cancer.

S. Agelaki, D. Mavroudis, V. Georgoulias, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study.

V. Georgoulias, K. Syrigos, N. Ziras, 2006, Lung cancer.

Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report.

S. Agelaki, V. Georgoulias, G. Samonis, 2000, Seminars in oncology.

Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group.

V. Georgoulias, A. Kalykaki, D. Mavroudis, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy.

S. Agelaki, V. Georgoulias, A. Kalykaki, 2008, Lung cancer.

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

V. Georgoulias, A. Voutsina, D. Mavroudis, 2012, British Journal of Cancer.

Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer: A Phase II Study

V. Georgoulias, A. Kalykaki, N. Vardakis, 2009, Oncology.

Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial.

K. Syrigos, V. Georgoulias, I. Boukovinas, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose Escalation Study on Oxaliplatin and Capecitabine (Xeloda) in Patients with Advanced Solid Tumors

S. Agelaki, V. Georgoulias, G. Samonis, 2004, Oncology.

Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.

M. Tzardi, S. Agelaki, V. Georgoulias, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer

S. Agelaki, D. Mavroudis, V. Georgoulias, 2011, Cancer Chemotherapy and Pharmacology.

Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group.

V. Georgoulias, G. Mountzios, N. Karachaliou, 2012, Lung cancer.

Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.

S. Agelaki, V. Georgoulias, D. Mavroudis, 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

D. Mavroudis, V. Georgoulias, I. Boukovinas, 2012, Cancer Chemotherapy and Pharmacology.

Prognostic significance of the detection of peripheral blood CEACAM5 mRNA-positive cells by real-time polymerase chain reaction in operable colorectal cancer (CRC)

D. Mavroudis, V. Georgoulias, I. Koutroubakis, 2010 .